Meet us at these European research events in 2019


Find out more

Our Mission

As a unique alliance of NGOs and healthcare companies, EURADIA’s mission is to improve the lives of people affected by diabetes both now and in the future, through advocacy of diabetes research in Europe at the highest political and societal levels of influence, by improving coordination of European diabetes research and by shaping the allocation of resources for such research through increased awareness.

What is EURADIA

Who we are: EURADIA is an alliance of non-governmental organisations (NGOs) and healthcare companies working for diabetes research. The NGOs include European academic and clinical researchers, healthcare professionals and patient groups.

What we do: We provide a platform for all those undertaking research to work together to benefit the wellbeing of people with diabetes, through advocacy for increased funding and improved coordination of diabetes research in Europe.

A Brief History of EURADIA

EURADIA began in 2003 as a collaboration of NGOs and healthcare companies with an interest in supporting and promoting diabetes research at European Level.

This successful collaboration has grown in number of stakeholders and has a Secretariat based in the UK.

EURADIA is an independent charity registered with the Charity Commission for England and Wales.


The Horizon Impact Award celebrates the use of research results to create value for the society. Hurry up and apply before 28 May! #H2020 #HorizonEU #ResearchImpactEU

More info➡️https://t.co/wpnUPn74nk

We're delighted to be in #Tirana for our #postgraduate courses on #diabetes and its complications. #easdpg_al brings 150 participants from 16 countries together for 3 days of interaction and hands-on learning!

JDRF's CEO in the UK @KarenFAddington marks 40 years since her #type1diabetes diagnosis: "This story is why I fight for better treatments, for prevention, and for a cure for type 1 diabetes."
Read more: https://t.co/Vmtubb1BzG #Diaversary

Excited to be representing @DiabetologiaJnl at the EASD Islet Study Group meeting in Oxford! @ISLETSINOX2019 @EASDnews

Chairman Dr Xavier Cos spoke today about personalized medicine in primary care at the 2nd symposium on Precision Medicine in Diabetic Kidney Disease Stakeholders’ Perspectives in Amsterdam. @PCDEurope , https://t.co/B4wGcEbqxY

Here is our latest bulletin with information about funding for diabetes research

Load More...